Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, November 4, 2019

ORA is experiencing staffing issues and we ask your patience while we fill the positions.  To ensure that we

are able to provide thorough support, please route your proposals and documents as soon as possible.  Thank you.



The Office of Technology Development will offer the Innovation to Impact Series Session 4 – “Post Graduate

Venture Fellowship Program.” Hear from a current Venture Fellow commercializing technology from his graduate

research; Explore the skills needed for a career in industry or entrepreneurship and  Learn about program details,

including selection, curriculum and goals. Vince Sandifer, current Venture Fellow, will be presenting. This session

will occur on November 20th  from Noon- 1:00 pm in Biomedical Research Center Building,  Room 103. Lunch will

be provided. Please RSVP to by November 14th. Space is limited to the first 15 attendees.



NIH Requests Public Comment on a Draft Policy for Data Management and Sharing and

Supplemental Draft Guidance

Today, NIH released a Draft NIH Policy for Data Management and Sharing and supplemental draft guidance for

public comment.  The purpose of this draft policy and supplemental draft guidance is to promote effective and

efficient data management and sharing that furthers NIH’s commitment to making the results and accomplishments

of the research it funds and conducts available to the public. Complete information about the draft Policy and draft

supplemental guidance can be found on the NIH OSP website

Stakeholder feedback is essential to ensure that any future policy maximizes responsible data sharing, minimizes

burden on researchers, and protects the privacy of research participants.  Stakeholders are invited to comment

on any aspect of the draft policy, the supplemental draft guidance, or any other considerations relevant to NIH’s

data management and sharing policy efforts that NIH should consider.

To facilitate commenting, NIH has established a web portal that can be accessed here: To ensure consideration, comments must be

received no later than January 10, 2020.  For additional details about NIH’s thinking on this issue, please

see Dr. Carrie Wolinetz’ latest Under the Poliscope blog:

NIH’s DRAFT Data Management and Sharing Policy: We Need to Hear From You!

NIH will also be hosting a webinar on the draft policy in the near future.  Please stay tuned for details.

Questions may be sent to



New “All About Grants” Podcast on Managing Conflicts of Interest in Peer Review

In this next installment of the NIH’s All About Grants podcast series, we talk about how NIH manages conflicts

of interest to ensure that we maintain integrity throughout the peer review process. Sally Amero, Ph.D., NIH’s

Review Policy Officer, joins us and explains why it is important to manage these conflicts, what is and is not a

potential conflict, how to disclose conflicts, and who is involved throughout the peer review process.


NIH: All pending support at the time of application submission and prior to award must be reported using

"Just-in-Time Procedures" by providing all information indicated above. Applicants are responsible for promptly

notifying NIH of any substantive changes to previously submitted Just-in-Time information up to the time of award,

including "Other Support" changes that must be assessed for budgetary or scientific overlap. Further, if other

support, as described as above, is obtained after the initial NIH award period, from any source either through the

institution or directly to senior/key personnel, the details must be disclosed in the annual research performance

progress report (RPPR). Post-award, recipients must address any substantive changes by submitting a prior

approval request to NIH in accordance with the NIHGPS section on "Administrative Requirements-Changes in

Project and Budget-NIH Standard Terms of Award."

See NOT-OD-19-114



GCA Newsletter for November 2019 is attached. News November 2019.pdf?ver=2019-11-04-083855-253





The primary objective of the PHF Bridge Grant program is to provide funding to enhance OUHSC faculty

competitiveness for extramural funding. OUHSC Principal Investigators who have submitted an extramural

application that was scored but not funded within the past 18 months and is requesting over $750,000 in total

direct costs and over $200,000 in total facilities and administration (F&A) costs and received a review that

ranks applications and provides critiques are eligible.  This program can provide funding for up to $75,000 for

one year. Guidelines and Application Form is attached or can be found at: Grant Guidelines - 2019-October 23 2019-Revised.docx?ver=2019-10-28-083210-947


END2Cancer: Emerging Nanotechnology and Drug Delivery
Applications for Cancer Conference
November 20 - 22, 2019
Samis Education Center at the OU Children's Hospital, Oklahoma City

Click here to register:



Pat Tillman Foundation Informational WorkshopNovember 20, 2019 from 12:00PM to 1:00PM at

the David L. Boren Student Union, Room 260.



Office of Technology Development presents a fifth opportunity to engage with industry (click here for more information, or email or

for specific submission details):

  1. UCB is looking to engage with academia in the gene therapy space for developing new treatments

for neurological disorders.  Focus areas* include:

  1. Viral delivery approaches using AAV or non-viral approaches (e.g., LNPs or EVs)
  2. Accessory approaches facilitating better delivery/enhanced expression of genes
  3. Approaches targeting gene therapy candidates and their allied pathways
  4. Out of scope: lentiviral or antisense oligonucleotide delivery approaches (unless transformed for use

in AAV)

*Basic/pre-clinical research stages are within scope; however, highest priority is research with existing

in vivo validation.  Non-confidential, 1-3 page application due 11/29/2019.



This Workshop has been postponed: UPDATE!   Don’t miss out!  ORA/GCA/Purchasing Workshop

Ever wondered who we are and what we do?

Ever needed help with a grant submission?

Not quite sure how to support your faculty with their grants and contracts?

Are you struggling with a human subjects section of your proposal?

Are budget and compliance questions keeping you from your real job?

Finally the moment you’ve been waiting for….

We are pleased to announce a joint workshop, “The OUHSC World of Grants & Contracts” for faculty and

staff.  This workshop will offer a one-day training on sponsored research topics.  The sessions are the same

for both days, just different times.  The information will be provided in a variety of formats ranging from talks

to breakout sessions with experts sitting at tables eager to answer all your questions.



Harold Hamm Diabetes Center (HHDC) Research Symposium

The 2019 HHDC Research Symposium will be held on Friday, November 15, 2019 at the Samis Education

Center in Children’s Hospital in Oklahoma City. The Symposium will consist of selected oral presentations,

a poster session, and Symposia talks by P. Darrell Neufer, PhD, Professor, East Carolina University,

Matthew Rodeheffer PhD, Associate Professor, Yale University and Scott Summers, PhD, Professor and

Chair, The University of Utah. For abstract submission guidelines and to RSVP for this free event, please

go to:  

Please contact with any questions for this event.



i2E Entrepreneurial Summit on Friday, November 15, 2019 at 9:00 am – 1:00 pm at the Reed

Conference Center, Midwest City 73110.  See attached document for more complete information.



NIH Extension Policy for Eligibility Window for Pathway to Independence Awards (K99/R00)


FSMA Preventive Controls and Mutual Reliance Implementation Expansion Supplement to RFA-FD-18-001


Notice of Pre-Application Webinar for PA-18-817 "Administrative Supplements for Research on Dietary

Supplements" and PA-18-818 "Administrative Supplements for Validation Studies of Analytical Methods

for Dietary Supplement Constituents" (NOT-OD-20-014)


Request for Information (RFI): Input on Research Opportunities on the Anterior Segment of the Eye


Notice to Rescind NOT-AA-19-025 "Notice of Intent to Publish a Funding Opportunity Announcement for

Early Liver Transplantation Cohort Study (U10 - Clinical Trial Optional) " (NOT-AA-19-030)


Notice to Extend the Expiration Date for PAR-17-032 (NOT-AG-20-005)

Notice to Remove the Letter of Intent Due Date from PAS-19-391, PAS-19-392, and PAS-19-393

Notice to Extend the Expiration Date for PAR-17-033 (NOT-AG-20-007)

Clarification of Research Areas for NIAID RFA-AI-19-059: Accelerating Discovery of Efficacious

Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed) (NOT-AI-20-006)


Notice to Extend the Response Date for NOT-AR-19-039 "Request for Information (RFI) on the Lessons

Learned from the Accelerating Medicines Partnership Rheumatoid Arthritis and Lupus (AMP RA/SLE

Program)" (NOT-AR-20-008)


Notice of Additional Research Objectives for PAS-19-105, Stimulating Hematology Investigation: New

Endeavors (SHINE) (R01 Clinical Trial Not Allowed) (NOT-DK-19-028)


Notice of Additional Receipt Date for PAR-18-925, Pragmatic Research in Healthcare Settings to Improve

Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required) (NOT-DK-20-006)


Notice of Additional Receipt Date for PAR-18-924, Planning Grants for Pragmatic Research in Healthcare

Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required) (NOT-DK-20-007)


Notice of Additional Receipt Date for PAR-17-178, Evaluating Natural Experiments in Healthcare to

Improve Diabetes Prevention and Treatment (R18) (NOT-DK-20-008)


Notice of Intent to Publish the Reissuance of PAR-18-644 and PAR-18-645 for Research Infrastructure

Development for Interdisciplinary Aging Studies (R33 and R21/R33) (NOT-AG-20-004)


Notice of Intent to Publish a Funding Opportunity Announcement for Implementing the HIV Service

Cascade for Justice-Involved Populations (NOT-DA-20-003)


Notice of Special Interest (NOSI) of NIDCR in Supporting Discovery, Characterization, and Mechanistic

Study of Genetic Variants Underlying Dental, Oral, and Craniofacial Diseases and Conditions (NOT-DE-19-016)


Notice of Special Interest: Development of Swallowable Smart Pills or Devices for Precision Nutrition,

Microbiome and Digestive Disease Applications (NOT-DK-20-001)


Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.





Communication and Decision Making for Individuals with Inherited Cancer Syndromes

(U01 Clinical Trial Optional) (RFA-CA-20-006) - Deadline January 21, 2020


Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets

(R61/R33 Clinical Trial Not Allowed) (RFA-NS-20-007) – Deadline March 17, 2020 





National Science Foundation (NSF) EPSCoR Research Infrastructure Improvement Program:

Track 2 Solicitation – Required Letter of Intent Due December 20, 2019; Full Proposal Due January 24, 2020





American Brain Tumor Association – Basic Research Fellowships – Deadline for Required

Letter of Intent is December 4, 2019


American Brain Tumor Association – Discovery Grants – Deadline for Required Letter of Intent is

December 4, 2019


Oklahoma Center for Adult Stem Cell Research (OCASCR) – Grant Deadline January 28, 2010